Related references
Note: Only part of the references are listed.Cardiovascular events among reproductive and menopausal age women with polycystic ovary syndrome: a systematic review and meta-analysis
Fahimeh Ramezani Tehrani et al.
GYNECOLOGICAL ENDOCRINOLOGY (2020)
Long-term cardiometabolic disease risk in women with PCOS: a systematic review and meta-analysis
V Wekker et al.
HUMAN REPRODUCTION UPDATE (2020)
Risk of Cardiovascular and Cerebrovascular Events in Polycystic Ovarian Syndrome Women: A Meta-Analysis of Cohort Studies
Jun Zhang et al.
FRONTIERS IN CARDIOVASCULAR MEDICINE (2020)
Data resource profile: Clinical Practice Research Datalink (CPRD) Aurum
Achim Wolf et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2019)
Impaired Lipolysis, Diminished Fat Oxidation, and Metabolic Inflexibility in Obese Girls With Polycystic Ovary Syndrome
Joon Young Kim et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2018)
Cardiovascular disease in a nationwide population of Danish women with polycystic ovary syndrome
Dorte Glintborg et al.
CARDIOVASCULAR DIABETOLOGY (2018)
Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome
Helena J. Teede et al.
CLINICAL ENDOCRINOLOGY (2018)
High Androgens in Postmenopausal Women and the Risk for Atherosclerosis and Cardiovascular Disease: The Rotterdam Study
Cindy Meun et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2018)
Coronary artery disease risk in young women with polycystic ovary syndrome
Dah-Ching Ding et al.
Oncotarget (2018)
Association between polycystic ovary syndrome and the risk of stroke and all-cause mortality: insights from a meta-analysis
Yaqiong Zhou et al.
GYNECOLOGICAL ENDOCRINOLOGY (2017)
Preventing type 2 diabetes: systematic review of studies of cost-effectiveness of lifestyle programmes and metformin, with and without screening, for pre-diabetes
Samantha Roberts et al.
BMJ OPEN (2017)
Influence of race/ethnicity on cardiovascular risk factors in polycystic ovary syndrome, the Dallas Heart Study
Alice Y. Chang et al.
CLINICAL ENDOCRINOLOGY (2016)
Weight Gain and Dyslipidemia in Early Adulthood Associate With Polycystic Ovary Syndrome: Prospective Cohort Study
Meri-Maija E. Ollila et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2016)
Cardiovascular Disease and 10-Year Mortality in Postmenopausal Women with Clinical Features of Polycystic Ovary Syndrome
C. Noel Bairey Merz et al.
JOURNAL OF WOMENS HEALTH (2016)
Polycystic ovary syndrome (PCOS) and the risk of coronary heart disease (CHD): a meta-analysis
Luqian Zhao et al.
ONCOTARGET (2016)
Rheumatoid Arthritis Disadvantages Younger Patients for Cardiovascular Diseases: A Meta-Analysis
Jaap Fransen et al.
PLOS ONE (2016)
Morbidity and medicine prescriptions in a nationwide Danish population of patients diagnosed with polycystic ovary syndrome
Dorte Glintborg et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2015)
Post-menopausal Women With a History of Irregular Menses and Elevated Androgen Measurements at High Risk for Worsening Cardiovascular Event-Free Survival: Results From the National Institute of Health-National Heart, Lung, and Blood Institute (NHLBI)-sponsored Women's Ischemia Syndrom Evaluation (WISE) (vol 93, pg 1276, 2008)
L. Shaw
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
The Potential Implications of a PCOS Diagnosis on a Woman's Long-Term Health Using Data Linkage
Roger Hart et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
Black women with polycystic ovary syndrome (PCOS) have increased risk for metabolic syndrome and cardiovascular disease compared with white women without PCOS
Jennifer K. Hillman et al.
FERTILITY AND STERILITY (2014)
Risk of coronary heart disease and risk of stroke in women with polycystic ovary syndrome: A systematic review and meta-analysis
Sarah A. Anderson et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2014)
Epidemiology and Comorbidities of Polycystic Ovary Syndrome in an Indigent Population
Susan M. Sirmans et al.
JOURNAL OF INVESTIGATIVE MEDICINE (2014)
Endothelial function measured using flow-mediated dilation in polycystic ovary syndrome: a meta-analysis of the observational studies
Victoria S. Sprung et al.
CLINICAL ENDOCRINOLOGY (2013)
Diabetes and cardiovascular events in women with polycystic ovary syndrome: a 20-year retrospective cohort study
Hamidreza Mani et al.
CLINICAL ENDOCRINOLOGY (2013)
The sympathetic nervous system in polycystic ovary syndrome: a novel therapeutic target?
Andrew Lansdown et al.
CLINICAL ENDOCRINOLOGY (2012)
Evaluation of Adverse Outcome in Young Women with Polycystic Ovary Syndrome Versus Matched, Reference Controls: A Retrospective, Observational Study
Christopher L. Morgan et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
PCOS, coronary heart disease, stroke and the influence of obesity: a systematic review and meta-analysis
P. C. M. de Groot et al.
HUMAN REPRODUCTION UPDATE (2011)
Cardiovascular Disease and Risk Factors in PCOS Women of Postmenopausal Age: A 21-Year Controlled Follow-Up Study
Johanna Schmidt et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Global adiposity rather than abnormal regional fat distribution characterizes women with polycystic ovary syndrome
Thomas M. Barber et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Postmenopausal women with a history of irregular menses and elevated androgen measurements at high risk for worsening cardiovascular event-free survival: Results from the National Institutes of Health - National heart, lung, and blood institute sponsored women's ischemia syndrome evaluation
Leslee J. Shaw et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Cardiovascular actions of insulin
Ranganath Muniyappa et al.
ENDOCRINE REVIEWS (2007)
Epidemiology and adverse cardiovascular risk profile of diagnosed polycystic ovary syndrome
JC Lo et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Overweight women with polycystic ovary syndrome have evidence of subclinical cardiovascular disease
C Meyer et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Phenotypic variation in hyperandrogenic women influences the findings of abnormal metabolic and cardiovascular risk parameters
E Carmina et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Evidence for an association between metabolic cardiovascular syndrome and coronary and aortic calcification among women with polycystic ovary syndrome
EO Talbott et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
WC Knowler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Evidence for association between polycystic ovary syndrome and premature carotid atherosclerosis in middle-aged women
EO Talbott et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2000)
Cardiovascular disease in women with polycystic ovary syndrome at long-term follow-up: a retrospective cohort study
S Wild et al.
CLINICAL ENDOCRINOLOGY (2000)
Share Paper
